Literature DB >> 7040263

Rifampicin treatment of cutaneous leishmaniasis.

Z Even-Paz, L Weinrauch, R Livshin, J El-On, C L Greenblatt.   

Abstract

In a small-scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040263     DOI: 10.1111/j.1365-4362.1982.tb00517.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Use of in vitro method to assess different brands of anti-leishmanial drugs.

Authors:  S K Arora; R Sinha; S Sehgal
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Cutaneous leishmaniasis: failure of topical treatment with imidazole derivatives in laboratory animals and man.

Authors:  L Weinrauch; R Livshin; G P Jacobs; J El-On
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Efficacy of ketoconazole in cutaneous leishmaniasis.

Authors:  L Weinrauch; R Livshin; Z Even-Paz; J El-On
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

4.  Interaction of aminoglycosides and ionophores in the killing of Crithidia fasciculata.

Authors:  M A Millgram; C L Greenblatt; J Shlomai
Journal:  Z Parasitenkd       Date:  1985

Review 5.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 6.  Advances in Development of New Treatment for Leishmaniasis.

Authors:  Juliana Perrone Bezerra de Menezes; Carlos Eduardo Sampaio Guedes; Antônio Luis de Oliveira Almeida Petersen; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

7.  Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen.

Authors:  Elizabeth R Sharlow; David Close; Tongying Shun; Stephanie Leimgruber; Robyn Reed; Gabriela Mustata; Peter Wipf; Jacob Johnson; Michael O'Neil; Max Grögl; Alan J Magill; John S Lazo
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03

8.  Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient.

Authors:  Hamida Al-Dwibe; Aisha Gashout; Abdu-Maged Morogum; Said El-Zubi; Ahmad Amro
Journal:  Parasit Vectors       Date:  2014-08-29       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.